BDBM221785 US9314468, Table 7, Compound 72::US9314468, Table 9, Compound 5

SMILES CN1CCN(CC1)C(=O)Cn1c2ccccc2c2ccnc(CN(CCCCN)[C@H]3CCCc4cccnc34)c12

InChI Key InChIKey=JQTHZRINXVEAFM-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 221785   

TargetC-X-C chemokine receptor type 4(Human)
Altiris Therapeutics

US Patent
LigandPNGBDBM221785(US9314468, Table 9, Compound 5 | US9314468, Table ...)
Affinity DataIC50: 30nMT: 2°CAssay Description:Functional modulation of CXCR4 was determined by calcium mobilization assay using leukemic lymphoid CEM cells, which naturally express high levels of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2017
Entry Details
US Patent

TargetC-X-C chemokine receptor type 4(Human)
Altiris Therapeutics

US Patent
LigandPNGBDBM221785(US9314468, Table 9, Compound 5 | US9314468, Table ...)
Affinity DataIC50: 30nMT: 2°CAssay Description:Functional modulation of CXCR4 was determined by calcium mobilization assay using leukemic lymphoid CEM cells, which naturally express high levels of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2017
Entry Details
US Patent